CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$14.6B
(+22%)
Cap. Flow
+$971M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
365
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Medtronic
MDT
$119B
| $5K | ﹤0.01% |
37
-1
| -3% | -$135 |
|
827
GSK
GSK
$79.9B
| $4K | ﹤0.01% |
92
-5
| -5% | -$217 |
|
828
Trane Technologies
TT
$92.5B
| $4K | ﹤0.01% |
22
+2
| +10% | +$364 |
|
|
RDS.A
829
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4K | ﹤0.01% |
91
+67
| +279% | +$2.95K |
|
830
Arrow Electronics
ARW
$6.51B
| $3K | ﹤0.01% |
22
-9
| -29% | -$1.23K |
|
831
Telefonica
TEF
$30.2B
| $3K | ﹤0.01% |
604
+62
| +11% | +$308 |
|
832
Banco Bilbao Vizcaya Argentaria
BBVA
$104B
| $2K | ﹤0.01% |
307
+187
| +156% | +$1.22K |
|
833
Eaton
ETN
$136B
| $2K | ﹤0.01% |
16
-1
| -6% | -$125 |
|
834
Garmin
GRMN
$46.5B
| $2K | ﹤0.01% |
17
+8
| +89% | +$941 |
|
835
Novo Nordisk
NVO
$251B
| $2K | ﹤0.01% |
28
-1
| -3% | -$71 |
|
836
Rio Tinto
RIO
$102B
| $2K | ﹤0.01% |
21
-10,698
| -100% | -$1.02M |
|
837
TE Connectivity
TEL
$61B
| $2K | ﹤0.01% |
18
-14
| -44% | -$1.56K |
|
|
WBK
838
DELISTED
Westpac Banking Corporation
WBK
| $2K | ﹤0.01% |
97
| – | – |
|
839
Accenture
ACN
$162B
| $1K | ﹤0.01% |
+4
| New | +$1K |
|
840
BP
BP
$90.8B
| $1K | ﹤0.01% |
47
-63
| -57% | -$1.34K |
|
841
Equinor
EQNR
$62.1B
| $1K | ﹤0.01% |
66
-6
| -8% | -$91 |
|
842
Linde
LIN
$224B
| $1K | ﹤0.01% |
5
+1
| +25% | +$200 |
|
843
Merus
MRUS
$4.98B
| $1K | ﹤0.01% |
+44
| New | +$1K |
|
844
SAP
SAP
$317B
| $1K | ﹤0.01% |
+10
| New | +$1K |
|
845
Sumitomo Mitsui Financial
SMFG
$105B
| $1K | ﹤0.01% |
137
+131
| +2,183% | +$956 |
|
846
Takeda Pharmaceutical
TAK
$47.3B
| $1K | ﹤0.01% |
+78
| New | +$1K |
|
847
TotalEnergies
TTE
$137B
| $1K | ﹤0.01% |
+15
| New | +$1K |
|
848
Vodafone
VOD
$28.8B
| $1K | ﹤0.01% |
55
+7
| +15% | +$127 |
|
|
BBL
849
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $1K | ﹤0.01% |
23
-23
| -50% | -$1K |
|
850
NovoCure
NVCR
$1.38B
| $1K | ﹤0.01% |
3
+1
| +50% | +$333 |
|